Blockchain on the pharmaceutical supply chain management market – DataM Intelligence
Blockchain on the pharmaceutical supply chain management market was estimated at $ 1.27 billion in 2024 and is expected to reach $ 6.57 billion by 2033, extending to an annual growth rate (TCAC) of 21.5% during the forecast period from 2025 to 2033.
The DataM Intelligence pharmaceutical supply chain report provides complete information and analyzes on key market trends, growth opportunities and emerging challenges. With a commitment to provide usable information, Datam Intelligence allows companies to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the company provides in -depth reports that help customers navigate in complex market dynamics, stimulate strategic growth and seize new opportunities in a constantly evolving global landscape.
Download your example of an exclusive report: (business email gets priority access): https://datamintelligence.com/download-sample/blockchain-in-pharmaceutical-supply-chain-market?
Blockchain in the analysis of the landscape of the management of the pharmaceutical supply chain:
Blockchain is a great decentralized and distributed book technology that records transactions safely on several computers, guaranteeing the integrity and transparency of data. In the pharmaceutical supply chain, the blockchain allows an unalterable and transparent recording of each manufacturing and distribution step by step to delivery to end users. This allows all key stakeholders, including manufacturers, distributors, pharmacies and regulatory authorities, to access real -time and verifiable information on the origin, status and authenticity of pharmaceuticals.
The cryptographic foundation of the blockchain ensures that sensitive data is protected against unauthorized access and falsification. In addition, the blockchain supports automation via smart contracts, which can rationalize routine tasks, reduce administrative charges and speed up workflows in the supply chain.
The main drivers of market growth include improving data security, improved transparency and complete traceability of pharmaceutical products. These capacities are particularly essential to solve the global problem of counterfeit drugs.
For example, in November 2024, the Ethiopia Food and Drug Authority (EFDA) joined the medical value chain to deploy a pharmaceutical monitoring system based on blockchain. This initiative aims to combat the distribution of counterfeit drugs and to guarantee the authenticity and safety of pharmaceutical products in the health care chain in Ethiopia.
Blockchain on the pharmaceutical supply chain management market: industry change trends and market potential
Improved safety, transparency and traceability stimulating market growth
Data security, improved transparency and traceability are among the main factors feeding blockchain growth on the pharmaceutical supply chain management market. While the pharmaceutical sector is struggling with persistent challenges such as counterfeit drugs, data violations and strict regulatory requests, blockchain has become a transformative solution capable of responding to these critical problems.
One of the remarkable advantages of blockchain technology is its solid security architecture. By using a large decentralized and impregnated book, the blockchain guarantees that each transaction and data point are saved and cannot be modified or deleted without appropriate authorization. This level of integrity considerably reduces the risk of data handling and offenses commonly associated with traditional centralized systems.
Data security remains an urgent concern. For example, in 2023, violations of health care data affected more than 112 million people in 540 organizations, as indicated in the US office of the Ministry of Health and Social Services (HHS) for civil rights (OCR). This marks a sharp increase against 48.6 million individuals affected in 590 organizations in 2022. In addition, 2022 saw 11 violations involving more than a million files each, and 14 additional violations exceeded 500,000 files. Cryptographic guarantees of blockchain and decentralized infrastructure offer a convincing solution to such widespread vulnerabilities.
The growing threat is just as critical posed by counterfeit pharmaceutical products. According to Pfizer, counterfeit versions of at least 104 of its drugs have been discovered in more than 116 countries. The data from the pharmaceutical security institute (PSI) highlights the extent of the problem, with 6,897 counterfeit, illegal and theft incidents reported in 142 countries in 2023. These crimes involved more than 2,440 separate drugs and led to 4,894 arrests, the highest annual number recorded by the PSI in its 22 pharmaceutical.
Blockchain’s ability to ensure the traceability of end -to -end products is decisive in reducing the distribution of counterfeit drugs. By registering each stage of the course of a manufacturing product on delivery on a large unchanging book, the blockchain provides visibility and complete responsibility in the supply chain.
In summary, the convergence of the increase in data security threats and the global proliferation of counterfeit pharmaceuticals stimulate the urgent need for blockchain integration into pharmaceutical supply chains. Consequently, adoption should accelerate, strengthen the confidence, regulatory compliance and patient safety.
Make a request for the purchase of this report @ https://www.datamntelligence.com/enquiry/blockchain-in-pharmaceutical-supply-chain-magement-laket?sg
Strategic players leading the blockchain to the pharmaceutical market for the management of the supply chain in front: IBM, Microsoft, SAP SE, Oracle, Cloud Software Group, Inc., Auxesis Infotech PVT. Ltd., Omnichain Solutions, Walmart Inc., Farmatrust, Amazon Web Services, Inc, Vechain, Modum and Everledger.
Research methodology:
The blocchain global market study report in the pharmaceutical supply chain uses a complete double -source approach, integrating primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates several variables of influence of industry, in particular regulatory managers and government policies, market conditions in force, competitive intensity levels, data on historical performance, current market positioning, technological innovations and disruptions, emerging developments in industry, cross trade impacts, market prospects growth, potential market barriers and strategic challenges of industry challenges.
Covered segment in the blockchain on the pharmaceutical supply chain management market:
By offerings (platform, service)
By request (drug traceability, stock monitoring, intelligent contracts, compliance management, payment and regulations, others)
By type (private blockchain, public blockchain, hybrid blockchain)
By the end user (manufacturers, distributors, health care providers)
By region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)
Stay informed of the latest industry information by starting your subscription now: https://www.datamintelligence.com/reports-subscription?sg
Recent developments
✅ In September 2023, the Republic of Mauritius presented EVERIFY, an electronic blockchain electronic verification system. This initiative takes advantage of Blockchain technology to check and securely authenticate information and transactions in real time. The launch reflects Mauritius’ wider commitment to adopt emerging technologies such as blockchain, megadata, artificial intelligence (IA) and the Internet of Things (IoT), which collectively transform the way consumers are engaged with services and reshaping of traditional commercial models through sectors, including health care and pharmaceutical products.
Blockchain regional analysis on the pharmaceutical supply chain management market:
⇥ North America (United States, Canada, Mexico)
⇥ Europe (United Kingdom, Italy, Germany, Russia, France, Spain, Netherlands and the rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia remains from Asia-Pacific)
⇥ South America (Colombia, Brazil, Argentina, rest of South America)
⇥ Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, remains of the Middle East and Africa)
The most frequently asked questions in the blockchain in the market studies industry of the pharmaceutical supply chain:
➠ Who directs the blockchain in the pharmaceutical supply chain management industry and what is their competitive positioning concerning capacity, performance and profitability?
➠ What growth opportunities and the challenges of the market are faced with the Blockchain of the pharmaceutical management of the supplier supply chain?
➠ What segments show the highest growth potential and the distribution of market share?
➠ What factors stimulate or limit blockchain in the growth of the pharmaceutical supply chain?
➠ What are the dominant sales and distribution strategies in blockchain in the pharmaceutical supply chain management industry?
Contact us –
Company name: Datam Intelligence
Contact person: Sai Kiran
Email: sai.k@datamintelligence.com
Telephone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us –
Datam Intelligence is a market and consulting company that provides end -to -end trade solutions to consultation research organizations. At Datam Intelligence, we raise from our main trends, information and developments to emancipate rapid and clever solutions to customers like you. We include a multitude of union reports and personalized relationships with a robust methodology.
Our research database includes countless statistics and in -depth analyzes on a wide range of 6,300+ reports in more than 40 areas creating commercial solutions for more than more than more than more than 50 countries; Given the main commercial research needs that influence the growth trajectory of our vast customers.
This version was published on OpenPR.
